Growth Hormone Insensitivity Syndrome (GHIS) Completed Phase 2 / 3 Trials for Mecasermin (DB01277)

Also known as: Growth Hormone Insensitivity Syndrome

IndicationStatusPhase
DBCOND0036023 (Growth Hormone Insensitivity Syndrome (GHIS))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00571727Long-Term Treatment With rhIGF-1 in GHISTreatment